Pathologic findings in malignant hyperthermia: A case report and review of literature

American Journal of Forensic Medicine and Pathology

Volumn 25, Issue 4, 2004, Pages 327-333

  Christiansen, Lydia R ^a,b   Collins, Kim A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anesthesia; Death; Malignant hyperthermia; Rhabdomyolysis

Indexed keywords

CARBON DIOXIDE; SEVOFLURANE;

ADULT; ANAMNESIS; ANESTHESIST; AUTOPSY; BODY POSITION; BODY TEMPERATURE; BRADYCARDIA; CASE REPORT; GENERAL ANESTHESIA; HEART ARREST; HUMAN; HYPOTENSION; LOW BACK PAIN; LUMBAR VERTEBRA; MALE; MALIGNANT HYPERTHERMIA; MEDICAL LITERATURE; MUSCLE HEMATOMA; PATHOLOGY; PERITONEAL CAVITY; PEROPERATIVE COMPLICATION; PSOAS MUSCLE; RECORDING; REVIEW; STENOSIS; TRACHEA; VERTEBRA MALFORMATION;

DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; LOW BACK PAIN; MALE; MALIGNANT HYPERTHERMIA; MIDDLE AGED; MUSCLE, SKELETAL; SPINAL FUSION;

EID: 10044230403     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.paf.0000137345.49901.93     Document Type: Review

References (17)

1. Arbous MS, Grobbee DE, van Kleef JW, et al. Mortality associated with anaesthesia: a qualitative analysis to identify risk factors. Anaesthesia. 2001;56:1141-1153.
2. Robinson R, Hopkins P, Carsana A, et al. Several interacting genes influence the malignant hyperthermia phenotype. Hum Genet. 2003;112:217-218.
3. Start RD, Cross SS. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures. J Clin Pathol. 1999;52:640-652.
4. Neuberger J. Halothane hepatitis. Eur J Gastroenterol Hepatol. 1998;10:635-639.
5. Heggie JE. Malignant hyperthermia: considerations for the general surgeon. Can J Surg. 2002;45:369-372.
6. Anetseder M, Hager M, Muller CR, et al. Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. Lancet. 2002;359:1579-1580.
7. Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families. Anesthesiology. 2002;97:1067-1074.
8. Reuffert H, Olthoff D, Deutrich C, et al. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Acta Anaesthesiol Scand. 2002;46:692-698.
9. Karger B, Teige K. Fatal malignant hyperthermia: delayed onset and atypical course. Forensic Sci Int. 2002;129:187-190.
10. Prescott RJ, Roberts SP, Williams G. Malignant hyperpyrexia: a rare cause of postoperative death. J Clin Pathol. 1992;45:361-363.
11. Vorrakitpokatorn P, Limsakul A. Drug-induced hyperthermia and rhabdomyolysis during the perioperative period: report of three patients. J Med Assoc Thai. 2002;85:S884-S892.
12. Ward RJ, Eisele JW, Reay DT, et al. Hemolysis and hyperkalemia complicate malignant hyperpyrexia during anesthetic death. J Forensic Sci. 1986;31:543-545.
13. Kubo S, Orihara Y, Kitamura O, et al. An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle associated proteins and mitochondria. Forensic Sci Int. 2001;115:155-158.
14. Fenoglio JJ Jr, Irey NS. Myocardial changes in malignant hyperthermia. Am J Pathol. 1977;89:51-58.
15. Mezin P, Payen JF, Bosson JL, et al. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE), and negative (MHN) muscle biopsies. Br J Anaesth. 1997;79:327-331.
16. Harriman DGF. Malignant hyperthermia myopathy: a critical review. Br J Anaesth. 1988;60:309-316.
17. Hu J, Itsuro H, Inose M, et al. Characteristic expression of thrombomodulin in the muscle sarcoplasm in patients with the acute phase of rhabdomyolysis. Eur Neurol. 2000;43:174-180.